c.delgado

TL2 · Genoa

Contributes reviews on supplier material. Based in Genoa.

Joined 4 October 2024 · last posted 3d

76Posts here

1Topics

0Solutions

190Likes received

136Likes given

17Badges

98Days visited

1.1kPosts read

Recent activity

Full stream

PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #26 · Compounds › Oral incretins · 25 Jul 2026 · 26 likes Offering a way to settle PIONEER 6 cardiovascular safety rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
Common supplements people ask about, assessed one at a time Replied, post #92 · Practice › Interactions · 24 Jul 2026 · 3 likes I have no financial interest in anything named in this thread and I want to say so before I comment on common supplements, because it is the sort of subject where it…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #24 · Analytics › Mass spectrometry · 24 Jul 2026 · 8 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #97 · Evidence › Journal club · 21 Jul 2026 · 12 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would…
Seven-day rolling means and why weekly readings mislead Replied, post #74 · Outcomes › Progress reports · 21 Jul 2026 · 32 likes Worth stating the null on seven-day rolling before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #61 · Analytics › Home & field testing · 7 Jul 2026 · 10 likes The confident answers on consumer-accessible tests and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #27 · Compounds › Semaglutide · 4 Jul 2026 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #8 · Devices › Syringes & needles · 1 Jul 2026 · 7 likes On post #6 — agreed on the reasoning, with one qualification. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL…
Prescription requirements and telehealth models — a second dataset Replied, post #80 · Sourcing › Regulatory · 26 Jun 2026 · 0 likes Scheduling and prescription status are separate questions and the answer to one does not imply the other.
Publication patterns in the BPC-157 literature, examined Replied, post #9 · Compounds › Repair & healing peptides · 7 Jun 2026 · 6 likes The reason publication patterns is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #91 · Sourcing › Logistics · 4 Jun 2026 · 3 likes The arithmetic in post #90 is right; the assumption feeding it is the part to check. One more thing on Regional warehouse stock versus direct that took me far too long…
The best-written scientific paper you have read Replied, post #69 · Lounge › Off topic · 28 May 2026 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.